Imunon names Josh Blacher interim CFO effective July 1

Imunon, Inc.

Imunon, Inc.

IMNN

0.00
  • Imunon disclosed an interim CFO transition effective July 1, 2026.
  • Jeffrey Church will retire as interim CFO, ending a role he has held since January 2026.
  • Josh Blacher was appointed interim CFO, serving as principal financial officer and principal accounting officer.
  • Blacher is a Danforth Health employee since 2022, holding CFO consulting roles across life sciences companies.
  • He is also managing partner at Columbus Circle Capital, previously holding senior finance roles at several public companies.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Imunon Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-031292), on June 30, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.